IL209418A - History of benzyl-5,4-dihydropyrazole-1-carboxamide and drugs containing it for the treatment of malignant tumors - Google Patents

History of benzyl-5,4-dihydropyrazole-1-carboxamide and drugs containing it for the treatment of malignant tumors

Info

Publication number
IL209418A
IL209418A IL209418A IL20941810A IL209418A IL 209418 A IL209418 A IL 209418A IL 209418 A IL209418 A IL 209418A IL 20941810 A IL20941810 A IL 20941810A IL 209418 A IL209418 A IL 209418A
Authority
IL
Israel
Prior art keywords
dihydropyrazole
medicaments
benzyl
malignant tumors
carboxamide derivatives
Prior art date
Application number
IL209418A
Other languages
English (en)
Hebrew (he)
Other versions
IL209418A0 (en
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL209418A0 publication Critical patent/IL209418A0/en
Publication of IL209418A publication Critical patent/IL209418A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL209418A 2008-05-29 2010-11-18 History of benzyl-5,4-dihydropyrazole-1-carboxamide and drugs containing it for the treatment of malignant tumors IL209418A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008025750A DE102008025750A1 (de) 2008-05-29 2008-05-29 Dihydropyrazolderivate
PCT/EP2009/003030 WO2009143945A1 (de) 2008-05-29 2009-04-24 Dihydropyrazolderivate als tyrosinkinase modulatoren zur behandlung von tumoren

Publications (2)

Publication Number Publication Date
IL209418A0 IL209418A0 (en) 2011-01-31
IL209418A true IL209418A (en) 2015-09-24

Family

ID=40822993

Family Applications (1)

Application Number Title Priority Date Filing Date
IL209418A IL209418A (en) 2008-05-29 2010-11-18 History of benzyl-5,4-dihydropyrazole-1-carboxamide and drugs containing it for the treatment of malignant tumors

Country Status (16)

Country Link
US (1) US8404685B2 (enExample)
EP (1) EP2300434B1 (enExample)
JP (1) JP5643192B2 (enExample)
KR (1) KR20110010821A (enExample)
CN (1) CN102046605B (enExample)
AR (1) AR071951A1 (enExample)
AU (1) AU2009253432B2 (enExample)
BR (1) BRPI0912970A2 (enExample)
CA (1) CA2726009C (enExample)
DE (1) DE102008025750A1 (enExample)
EA (1) EA018394B1 (enExample)
ES (1) ES2507573T3 (enExample)
IL (1) IL209418A (enExample)
MX (1) MX2010012804A (enExample)
WO (1) WO2009143945A1 (enExample)
ZA (1) ZA201009085B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2726463B1 (en) 2011-07-01 2020-03-11 Merck Patent GmbH Dihydropyrazoles, pharmaceutical compositions thereof and their use for the treatment of fertility disorders
CA2878621C (en) * 2012-07-10 2020-09-15 Ares Trading S.A. Pyrimidine pyrazolyl derivatives
EP3886854A4 (en) 2018-11-30 2022-07-06 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
BR9707495A (pt) 1996-02-13 1999-07-27 Zeneca Ltd Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente
JP4464466B2 (ja) 1996-03-05 2010-05-19 アストラゼネカ・ユーケイ・リミテッド ４―アニリノキナゾリン誘導体
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
IL152682A0 (en) 2000-05-31 2003-06-24 Astrazeneca Ab Indole derivatives with vascular damaging activity
JP2004502766A (ja) 2000-07-07 2004-01-29 アンギオジェン・ファーマシューティカルズ・リミテッド 血管損傷剤としてのコルヒノール誘導体
CA2410562A1 (en) 2000-07-07 2002-01-31 Angiogene Pharmaceuticals Limited Colchinol derivatives as angiogenesis inhibitors
AU2003249597B2 (en) 2002-03-08 2007-06-28 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors
DE102005038537A1 (de) 2005-08-16 2007-02-22 Merck Patent Gmbh 1-Acyldihydropyrazolderivate

Also Published As

Publication number Publication date
JP5643192B2 (ja) 2014-12-17
JP2011520996A (ja) 2011-07-21
US20110071153A1 (en) 2011-03-24
WO2009143945A1 (de) 2009-12-03
EP2300434A1 (de) 2011-03-30
EP2300434B1 (de) 2014-07-23
CN102046605A (zh) 2011-05-04
HK1157345A1 (en) 2012-06-29
CA2726009C (en) 2016-08-23
US8404685B2 (en) 2013-03-26
MX2010012804A (es) 2010-12-07
CA2726009A1 (en) 2009-12-03
AU2009253432A1 (en) 2009-12-03
CN102046605B (zh) 2013-09-18
AR071951A1 (es) 2010-07-28
KR20110010821A (ko) 2011-02-07
DE102008025750A1 (de) 2009-12-03
ES2507573T3 (es) 2014-10-15
EA018394B1 (ru) 2013-07-30
ZA201009085B (en) 2011-10-26
AU2009253432B2 (en) 2013-08-01
IL209418A0 (en) 2011-01-31
BRPI0912970A2 (pt) 2015-10-13
EA201001831A1 (ru) 2011-06-30

Similar Documents

Publication Publication Date Title
PL2358697T3 (pl) Związki izoindolinowe do zastosowania w leczeniu raka
IL205759A (en) History of isoxazolo-pyridine, a process for their preparation and the drugs containing them
PL3069728T3 (pl) Nowa immunoterapia względem wielu nowotworów, w tym guzów neuronalnych i guzów mózgu
GB201008930D0 (en) Methods for stratifying and annotating cancer drug treatment options
ZA200805877B (en) Pyridiazinone derivatives for tumour treatment
EP2178531A4 (en) METHODS AND COMPOSITIONS, TARGETS FOR COMBINED CANCER TREATMENTS
IL202505A (en) 2-oxo-3-benzyl-benzoxazole-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumors, drugs containing them and their uses
IL208336A (en) Pyridazinone derivatives, drugs containing them and their uses and process for preparation
IL199696A0 (en) Specific therapy and medicament using integrin ligands for treating cancer
IL210869A (en) Derivatives of imidaziadiazoles, their process, preparation, uses and medications containing them
ZA201203449B (en) Sulfoxide derivatives for treating tumors
IL187327A0 (en) Methods for treating drug resistant cancer
ZA201003425B (en) 5-cyano-thienopyridines for the treatment of tumors
EP2148675A4 (en) ANTI-CANCER FOR THE DIAGNOSIS AND TREATMENT OF CANCER
IL238394A0 (en) Cancer treatment method
GB0804496D0 (en) Treating cancer
IL199911A0 (en) 3-cinnolinecarboxamide derivatives and their use for treating cancer
ZA201103627B (en) Prophylactic/therapeutic agent for cancer
IL209418A (en) History of benzyl-5,4-dihydropyrazole-1-carboxamide and drugs containing it for the treatment of malignant tumors
GB0609386D0 (en) Treating drug resistant cancers
PH12013500605A1 (en) 4-(methylaminophenoxy)pyrdin-3-yl-benzamide derivatives for treating cancer
GB0707556D0 (en) Treatment for cancer
IL226362A0 (en) compounds, and methods for treating cancer
ZA201104501B (en) New therapy and medicament using integrin ligands for treating cancer
ZA200807062B (en) Specific therapy using integrin ligands for treating cancer

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed